
A Study of Reported Factor VIII Use Around the World
Presents data on the reported use of factor VIII (FVIII) per country. FVIII use varies considerably, even among the wealthiest
Year: 2016
Language: English
This resource is also available in: Arabic French Russian Spanish Simplified Chinese
Author(s): World Federation of Hemophilia
Format: Document
This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking, and how infusion of replacement therapy works to achieve normal levels of blood clotting. It also illustrates the clotting factor cascade and highlights the points in the cascade where each type of hemophilia treatment product acts to impact the ability to form blood clots.

Presents data on the reported use of factor VIII (FVIII) per country. FVIII use varies considerably, even among the wealthiest

A summary of discussions held at the World Federation of Hemophilia’s Global Forum on the Safety and Supply of Hemophilia

Also Available In: Japanese A national tender is a cost-effective system for the purchase of products or services, such as

A comprehensive guide to creating and maintaining a successful contract fractionation program, from contract agreements to the fractionation process, the

Describes the manufacturing methods and characteristics of hemostatic products and their clinical indications for patients suffering with disorders.

This monograph outlines the treatment protocol used by healthcare providers in Georgia, U.S.A., as an example of a strategy to